Revised overall survival analysis of a phase II, randomized, double-blind, controlled study of PROSTVAC in men with metastatic castration-resistant prostate cancer Academic Article uri icon

Overview

MeSH Major

  • Communication
  • Consumer Health Information
  • Patient Preference
  • Prostatic Neoplasms
  • Survivors

publication date

  • January 2017

Research

keywords

  • Academic Article

Identity

Digital Object Identifier (DOI)

  • 10.1200/JCO.2016.69.7748

PubMed ID

  • 27646950

Additional Document Info

start page

  • 124

end page

  • 125

volume

  • 35

number

  • 1